Company · CIK 0001176309 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ORAMED PHARMACEUTICALS INC. · ORMP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 AForm 4 → | Sep 25, 4:31 pm EDT | Nadav KidronPresident and CEO, Director | 718,262 | — | — | 4,140,505 | — | |
| Sep 24, 2026 AForm 4 → | Sep 25, 4:31 pm EDT | Joshua HexterCOO & CBO | 284,746 | — | — | 1,358,130 | — | |
| Sep 24, 2026 AForm 4 → | Sep 25, 4:30 pm EDT | Miriam KidronChief Scientific Officer, Director | 417,416 | — | — | 1,550,554 | — | |
| Sep 24, 2026 AForm 4 → | Sep 25, 4:30 pm EDT | Avraham GabayChief Financial Officer | 209,291 | — | — | 881,076 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 DForm 4 → | Sep 25, 4:31 pm EDT | Nadav KidronPresident and CEO, Director | 789,500 | — | — | 0 | — | |
| Sep 24, 2026 DForm 4 → | Sep 25, 4:31 pm EDT | Joshua HexterCOO & CBO | 136,000 | — | — | 0 | — | |
| Sep 24, 2026 DForm 4 → | Sep 25, 4:30 pm EDT | Miriam KidronChief Scientific Officer, Director | 492,999 | — | — | 0 | — |